RJ Hamster
One drug candidate, six viruses – NNVC makes its…
A message from Equiscreen
NNVC’s Broad-Spectrum Antiviral NV-387 Could Be the Hidden Biotech Titan Ready to Disrupt Multi-Billion-Dollar Viral Markets!
NanoViricides (NYSE: NNVC) is quietly emerging as a potential powerhouse in antiviral therapy with its lead candidate, NV-387. Unlike conventional antivirals that target viral proteins and risk losing effectiveness as viruses mutate, NV-387 mimics human cell surfaces to trap and neutralize viruses at the point of entry.
Its broad-spectrum capabilities extend across RSV, influenza, coronaviruses, measles, Mpox, and even smallpox — creating the possibility for a single therapy to address multiple urgent public health threats simultaneously.
With preclinical studies showing complete cures in lethal RSV models and superior results against influenza compared to standard antivirals, NV-387 is generating excitement among biotech insiders.
NNVC has just completed manufacturing NV-387 oral gummies and is gearing up for Phase II trials in the Democratic Republic of Congo for Mpox. Coupled with FDA Orphan Drug Designation filings for Mpox and measles, NNVC is strategically positioned to accelerate regulatory approval while benefiting from tax incentives, fee waivers, and market exclusivity.
With a potentially $20+ billion market within reach and clinical validation underway, this small-cap biotech could be a rare opportunity for outsized gains.
Friday’s Featured Story
Why Netflix Tanked Despite Big EPS Beat, Outlook Ahead
Reported by Leo Miller. Article Posted: 4/17/2026.
Key Points
- Netflix stock took a huge hit after its latest earnings report, even as EPS rose by over 80%
- A leftover from its failed WBD deal created a one-time earnings uplift
- Meanwhile, a key leader departed, and Netflix extended its live sports success internationally
- Special Report: This SpaceX IPO news Makes Me Furious (From The Oxford Club)
Entertainment giant Netflix (NASDAQ: NFLX) just released one of its more anticipated earnings reports in some time. The firm’s latest report is its first since losing the battle against Paramount Skydance (NASDAQ: PSKY) to acquire Warner Bros. Discovery (NASDAQ: WBD). To Netflix’s dismay, the market reacted negatively to the results. Understanding why requires looking beyond the headline numbers. Considering Netflix’s long-term growth drivers but underwhelming near-term guidance, the stock’s risk-reward setup appears relatively balanced.
Netflix’s Huge EPS Beat Doesn’t Tell the Full Story
In its Q4 fiscal 2025 (FY2025), Netflix posted revenue of $12.25 billion, up roughly 16% year-over-year (YOY). (Note that Netflix’s fiscal year reporting period is about one quarter ahead of the calendar period.) That topped expectations of $12.17 billion.
The REAL Reason Trump is Invading Iran (Ad)
For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.Click here to find out what it is.
The company reported an even larger bottom-line beat. Diluted earnings per share rose to $1.23, an 86% YOY increase and well above estimates of $0.76. However, that result was boosted by a key one-time item.
After losing the WBD deal, Paramount paid Netflix a $2.8 billion termination fee. That payout significantly increased Netflix’s net income and EPS. Excluding the one-time fee, EPS would have come in below expectations.
That distinction likely contributed to the firm’s nearly 10% drop in after-hours trading, as the breakup-fee benefit had already been disclosed.
Another headwind was Netflix’s softer-than-expected guidance for the next quarter. It forecast revenue of $12.57 billion, or growth of 13.5% YOY, slightly below estimates of $12.64 billion. The company also expects its operating margin to decline 150 basis points YOY to 32.6%—though that would be a 30 basis-point improvement versus Q4 FY2025.
Netflix left its full-year guidance unchanged at $50.7 billion to $51.7 billion (a $51.2 billion midpoint), just under consensus of $51.37 billion.
Hastings’s Departure Causes Jitters
Investors were also unsettled by the news that Reed Hastings will not stand for re-election to Netflix’s Board of Directors. Hastings co-founded Netflix in 1997 and served as CEO for 25 years. He is currently the company’s board chairman and will remain in that role until June, after which he plans to focus on philanthropy and other ventures. His departure raises questions about the future of Netflix’s board leadership.
On the earnings call, one analyst asked whether the pursuit of WBD influenced Hastings’s decision. Hastings has long favored a “build over buy” approach, preferring organic growth to acquisitions. If the WBD effort had driven his exit, it might signal a misalignment among top executives. Co-CEO Ted Sarandos pushed back, saying, “Reed was a big champion for that deal,” adding that the board unanimously supported it and that the decision had “absolutely nothing to do” with Hastings’s departure.
Still, the timing is notable: after pursuing one of the largest M&A deals in media history, Hastings is stepping away. Either way, his exit marks the end of an era for Netflix’s direct involvement from its longtime leader.
Live Sports and Ads: Critical Levers for Netflix’s Future Growth
Looking ahead, sustained growth will be key to NFLX’s ability to deliver long-term gains. Live sports are one of the most promising avenues. Netflix had success broadcasting the World Baseball Classic (WBC) during the quarter: the company said the WBC was its most-watched program ever in Japan and drove the largest single-day sign-ups on the platform in that market, with Japan leading Netflix’s total Q1 membership growth.
This success builds on massive viewership Netflix generated from broadcasting NFL games and the Mike Tyson vs. Jake Paul boxing match. The WBC was Netflix’s first major live event outside the United States, offering a playbook the company can replicate in U.S. and international markets to grow membership.
Netflix’s advertising push also appears on track. The company expects to double ad sales to $3 billion in 2026 and reported its advertiser base grew 70% YOY to 4,000 companies. As its advertiser base expands, Netflix should be able to improve ad targeting and generate more revenue per ad, since marketers will derive greater value from the platform over time.
This email communication is a sponsored message for Equiscreen, a third-party advertiser of MarketBeat. Why did I get this message?.
This message is a paid advertisement for Nanoviricides (NNVC) from Equiscreen and Interactive Offers. MarketBeat Media, LLC receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $14,000. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Equiscreen or Interactive Offers. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Nanoviricides (NNVC) on Interactive Offers’ website for additional information about the relationship between Interactive Offers and Nanoviricides (NNVC).
If you have questions about your subscription, please email MarketBeat’s South Dakota based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Pl. #620, Sioux Falls, South Dakota 57103-7078. United States..
See Also: SpaceX gets new job from the Pentagon (Click to Opt-In)
